1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Kwality Pharmaceuticals Limited

Kwality Pharmaceuticals Limited

KPL.BO
Kwality Pharmaceuticals LimitedIN flagBombay Stock Exchange
2,586.95
INR
-66.25
- -
26.84BMarket Cap

Total Valuation

Kwality Pharmaceuticals Limited carries a market capitalization of 26.84B, placing it among publicly traded companies globally. Its enterprise value stands at 14.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap26.84B
Enterprise Value14.72B

Share Statistics

Kwality Pharmaceuticals Limited currently has 10.38M shares outstanding.

Shares Outstanding10.38M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Kwality Pharmaceuticals Limited trades at a trailing price-to-earnings ratio of 20.13. The price-to-sales ratio is 2.70, and the price-to-book ratio stands at 130.67.

PE Ratio20.13
PS Ratio2.70
PB Ratio130.67
P/TBV Ratio4.18
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Kwality Pharmaceuticals Limited trades at an EV/EBITDA multiple of 14.96 and an EV/FCF ratio of 178.33. The EV/Sales ratio of 2.93 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.96 provides insight into valuation relative to core operating earnings.

EV / Sales2.93
EV / EBITDA14.96
EV / EBIT14.96
EV / FCF178.33

Financial Position

Kwality Pharmaceuticals Limited maintains a current ratio of 1.80, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 39.54, indicating elevated leverage, while an interest coverage ratio of 8.97 demonstrates adequate ability to service its debt obligations.

Current Ratio1.80
Quick Ratio0.06
Debt / Equity39.54
Debt / EBITDA1.33
Interest Coverage8.97

Financial Efficiency

Kwality Pharmaceuticals Limited posts a return on equity of 50.80 and a return on invested capital of 17.44.

Return on Equity (ROE)50.80
Return on Assets (ROA)12.96
Return on Invested Capital (ROIC)17.44
Return on Capital Employed (ROCE)29.96
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.20

Taxes

Over the trailing twelve months, Kwality Pharmaceuticals Limited has paid 221.46M in income taxes, reflecting an effective tax rate of 24.75.

Income Tax221.46M
Effective Tax Rate24.75

Stock Price Statistics

Kwality Pharmaceuticals Limited's stock has gained approximately 121.60877% over the past 52 weeks. The 50-day moving average sits at 2,153.27, while the 200-day moving average is 1,401.43.

Beta (5Y)N/A
52-Week Price Change121.60877%
50-Day Moving Average2,153.27
200-Day Moving Average1,401.43
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Kwality Pharmaceuticals Limited generated 5.03B in revenue and converted that into 673.53M in net income, yielding earnings per share of 64.89. EBITDA reached 984.34M, while operating income came in at 984.34M.

Revenue5.03B
Gross Profit2.45B
Operating Income984.34M
Pretax Income894.92M
Net Income673.53M
EBITDA984.34M
EBIT984.34M
Earnings Per Share (EPS)64.89

Balance Sheet

Kwality Pharmaceuticals Limited holds 124.12M in cash and equivalents against 1.30B in total debt, resulting in a net debt position of 1.30B. Total book value stands at 103.76M, with working capital of 1.80B providing operational flexibility.

Cash & Cash Equivalents124.12M
Total Debt1.30B
Net Debt1.30B
Equity (Book Value)103.76M
Book Value Per Share10.00
Working Capital1.80B

Margins

Kwality Pharmaceuticals Limited operates with a gross margin of 48.63, reflecting its pricing power and cost economics. The operating margin of 19.57 and net profit margin of 13.39 provide insight into operational efficiency.

Gross Margin48.63
Operating Margin19.57
Pretax Margin17.79
Profit Margin13.39
EBITDA Margin19.57

Stock Splits

Kwality Pharmaceuticals Limited's most recent stock split took place on October 11, 2017 with a 1:2 split ratio.

Last Split Date10/11/2017
Split Ratio1:2

Scores

Kwality Pharmaceuticals Limited posts an Altman Z-Score of 4.88, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.88